Please report any queries concerning the funding data grouped in the
sections named
"Externally Awarded"
or
"Internally Disbursed"
(shown on the profile page) to your Research Finance Administrator.
Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php
by entering your department
Please report any queries concerning the student data shown on the
profile page to:
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
› More
search options
Miss Lucy Russell
Dementia Research Centre
8-11 Queen Square
London
WC1N 3AR
Tel: 020 344 83653
Appointment
- Research Fellow
- Neurodegenerative Diseases
- UCL Queen Square Institute of Neurology
- Faculty of Brain Sciences
Role
UCL Subsidiary Supervisor
Biography
2011-2015: BSc (Hons) Psychology from the University of Plymouth with a placement year at the Social, Genetic and Psychiatry Centre, Kings College London (2013-2014)
2015-2019: Research Assistant at the Dementia Research Centre, University College London
2020-Present: Research Fellow at the Dementia Research Centre, University College London
Research Summary
I am a postdoctoral researcher funded by the Bluefield Project. I have a BSc in Psychology from the University of Plymouth and joined Dementia Research Centre as a research assistant after graduating in 2015. I worked as the co-ordinator of the Londitudinal Investiogation of Frontotemporal Dementia (LIFTD) study and then started a part time PhD in 2016 along side this work. My PhD investigated the role of social cognition in FTD which included individuals from LIFTD, as well as from an international familial FTD study known as the Genetic Frontotemporal Dementia Initiative (GENFI). As part of my PhD I also developed a novel set of instructionless eye tracking tasks to study social cognition in FTD. I am now the co-ordinator of the FTD Prevention Initiative (FPI), helping to link together the genetic FTD cohort studies from around the world, and liaising with pharmaceutical companies as new drug trials start for people with FTD.
